Skip to main content
Year archive

Pharming Group N.V. — 2023 filings

All 64 regulatory filings released by Pharming Group N.V. (PHARM) in 2023, sourced directly from the official regulator.

64 Filings
2023 Period
2023 filings (64)
Filing Released Lang
6-K
Foreign Filer Report
2023-12-15 English
Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)
Regulatory Filings
2023-12-13 Dutch
Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)
Regulatory Filings
2023-12-13 English
Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib
Regulatory Filings
2023-11-21 English
Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib
Regulatory Filings
2023-11-21 English
6-K
Foreign Filer Report
2023-11-13 English
Pharming Group provides updates on EMA regulatory review of leniolisib MAA and plans to file for UK regulatory approval
Regulatory Filings
2023-11-10 English
Pharming Group provides updates on EMA regulatory review of leniolisib MAA and plans to file for UK regulatory approval
Regulatory Filings
2023-11-10 Dutch
6-K
Foreign Filer Report
2023-10-26 English
Pharming Group reports third quarter 2023 financial results
Earnings Release Q3 2023
2023-10-26 Dutch
Pharming Group reports third quarter 2023 financial results
Earnings Release Q3 2023
2023-10-26 English
6-K
Foreign Filer Report
2023-09-25 English
Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
AGM Information
2023-09-25 English
Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders
AGM Information
2023-09-25 English
Earnings Release 2023
Earnings Release H1 2023
2023-09-07 English
6-K
Foreign Filer Report
2023-08-14 English
Pharming Group to convene Extraordinary General Meeting of Shareholders
AGM Information
2023-08-14 Dutch
Pharming Group to convene Extraordinary General Meeting of Shareholders
AGM Information
2023-08-14 English
6-K
Foreign Filer Report
2023-08-09 English
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
Regulatory Filings
2023-08-09 Dutch
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
Regulatory Filings
2023-08-09 English
6-K
Foreign Filer Report
2023-08-03 English
Pharming Group reports second quarter and first half 2023 financial results
Earnings Release H1 2023
2023-08-03 English
Pharming Group reports second quarter and first half 2023 financial results
Interim / Quarterly Report H1 2023
2023-08-03 English
6-K
Foreign Filer Report
2023-07-18 English
Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board
Board/Management Information
2023-07-18 Dutch
Pharming to nominate industry leader Dr. Richard Peters as new Chairman of the Board
Board/Management Information
2023-07-18 English
6-K
Foreign Filer Report
2023-06-01 English
Pharming announces sale of priority review voucher
Regulatory Filings
2023-06-01 Dutch
Pharming announces sale of priority review voucher
Regulatory Filings
2023-06-01 English
6-K
Foreign Filer Report
2023-05-19 English
Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders
AGM Information
2023-05-19 English
Pharming Group reports on results of the 2023 Annual General Meeting of Shareholders
AGM Information
2023-05-19 English
Pharming Group reports financial results for the first quarter of 2023
Earnings Release Q1 2023
2023-05-11 English
Pharming Group reports financial results for the first quarter of 2023
Earnings Release Q1 2023
2023-05-11 English
6-K Filing
Foreign Filer Report
2023-05-11 English
6-K
Foreign Filer Report
2023-04-11 English
Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.
Regulatory Filings
2023-04-11 English
Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.
Earnings Release Q2 2023
2023-04-11 English
20-F
Annual Report FY 2022
2023-04-05 English
6-K
Foreign Filer Report
2023-04-05 English
Pharming Group announces the filing of its 2022 Annual Report and Form 20-F
Report Publication Announcement
2023-04-05 English
Pharming Group announces the filing of its 2022 Annual Report and Form 20-F
Report Publication Announcement
2023-04-05 English
Pharming Group convenes the Annual General Meeting of Shareholders 2023
AGM Information
2023-04-05 English
Pharming Group convenes the Annual General Meeting of Shareholders 2023
AGM Information
2023-04-05 English
Annual Report (ESEF) 2022
Annual Report (ESEF) FY 2022
2023-04-05 English
6-K
Foreign Filer Report
2023-03-27 English
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
Regulatory Filings
2023-03-27 English
Pharming announces US FDA approval of Joenja® (leniolisib) as the first and only treatment indicated for APDS
Regulatory Filings
2023-03-27 English
6-K
Foreign Filer Report
2023-03-16 English
Pharming Group reports financial results for full year 2022
Earnings Release FY 2022
2023-03-16 English
Pharming Group reports financial results for full year 2022
Earnings Release FY 2022
2023-03-16 English
6-K
Foreign Filer Report
2023-03-13 English
6-K
Foreign Filer Report
2023-03-13 English
Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank in light of US Government announcement
Regulatory Filings
2023-03-13 English
Pharming Group announces that it expects to have full access today to its cash on deposit at Silicon Valley Bank in light of US Government announcement
Earnings Release FY 2021
2023-03-13 Dutch
Pharming Group issues statement regarding the events surrounding Silicon Valley Bank
Legal Proceedings Report
2023-03-13 English
Pharming Group issues statement regarding the events surrounding Silicon Valley Bank
Regulatory Filings
2023-03-13 English
6-K
Foreign Filer Report
2023-02-21 English
Pharming announces first patient enrolled in pediatric clinical trial of leniolisib
Regulatory Filings
2023-02-21 Dutch
Pharming announces first patient enrolled in pediatric clinical trial of leniolisib
Regulatory Filings
2023-02-21 English
6-K
Foreign Filer Report
2023-02-17 English
Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe
Regulatory Filings
2023-02-16 Dutch
Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe
Regulatory Filings
2023-02-16 English